BACKGROUND: Proton Magnetic Resonance (MR) Spectroscopy (MRS) is a widely available technique for those clinical centres equipped with MR scanners. Unlike the rest of MR-based techniques, MRS yields not images but spectra of metabolites in the tissues. In pathological situations, the MRS profile changes and this has been particularly described for brain tumours. However, radiologists are frequently not familiar to the interpretation of MRS data and for this reason, the usefulness of decision-support systems (DSS) in MRS data analysis has been explored. RESULTS: This work presents the INTERPRET DSS version 3.0, analysing the improvements made from its first release in 2002. Version 3.0 is aimed to be a program that 1st, can be easily used with any new case from any MR scanner manufacturer and 2nd, improves the initial analysis capabilities of the first version. The main improvements are an embedded database, user accounts, more diagnostic discrimination capabilities and the possibility to analyse data acquired under additional data acquisition conditions. Other improvements include a customisable graphical user interface (GUI). Most diagnostic problems included have been addressed through a pattern-recognition based approach, in which classifiers based on linear discriminant analysis (LDA) were trained and tested. CONCLUSIONS: The INTERPRET DSS 3.0 allows radiologists, medical physicists, biochemists or, generally speaking, any person with a minimum knowledge of what an MR spectrum is, to enter their own SV raw data, acquired at 1.5 T, and to analyse them. The system is expected to help in the categorisation of MR Spectra from abnormal brain masses.
BACKGROUND: Proton Magnetic Resonance (MR) Spectroscopy (MRS) is a widely available technique for those clinical centres equipped with MR scanners. Unlike the rest of MR-based techniques, MRS yields not images but spectra of metabolites in the tissues. In pathological situations, the MRS profile changes and this has been particularly described for brain tumours. However, radiologists are frequently not familiar to the interpretation of MRS data and for this reason, the usefulness of decision-support systems (DSS) in MRS data analysis has been explored. RESULTS: This work presents the INTERPRET DSS version 3.0, analysing the improvements made from its first release in 2002. Version 3.0 is aimed to be a program that 1st, can be easily used with any new case from any MR scanner manufacturer and 2nd, improves the initial analysis capabilities of the first version. The main improvements are an embedded database, user accounts, more diagnostic discrimination capabilities and the possibility to analyse data acquired under additional data acquisition conditions. Other improvements include a customisable graphical user interface (GUI). Most diagnostic problems included have been addressed through a pattern-recognition based approach, in which classifiers based on linear discriminant analysis (LDA) were trained and tested. CONCLUSIONS: The INTERPRET DSS 3.0 allows radiologists, medical physicists, biochemists or, generally speaking, any person with a minimum knowledge of what an MR spectrum is, to enter their own SV raw data, acquired at 1.5 T, and to analyse them. The system is expected to help in the categorisation of MR Spectra from abnormal brain masses.
Authors: A Devos; L Lukas; J A K Suykens; L Vanhamme; A R Tate; F A Howe; C Majós; A Moreno-Torres; M van der Graaf; C Arús; S Van Huffel Journal: J Magn Reson Date: 2004-09 Impact factor: 2.229
Authors: Kirstie S Opstad; Mary M Murphy; Peter R Wilkins; B Anthony Bell; John R Griffiths; Franklyn A Howe Journal: J Magn Reson Imaging Date: 2004-08 Impact factor: 4.813
Authors: Sarah J Nelson; Edward Graves; Andrea Pirzkall; Xiaojuan Li; Antionette Antiniw Chan; Daniel B Vigneron; Tracy R McKnight Journal: J Magn Reson Imaging Date: 2002-10 Impact factor: 4.813
Authors: Arjan W Simonetti; Willem J Melssen; Marinette van der Graaf; Geert J Postma; Arend Heerschap; Lutgarde M C Buydens Journal: Anal Chem Date: 2003-10-15 Impact factor: 6.986
Authors: L Lukas; A Devos; J A K Suykens; L Vanhamme; F A Howe; C Majós; A Moreno-Torres; M Van der Graaf; A R Tate; C Arús; S Van Huffel Journal: Artif Intell Med Date: 2004-05 Impact factor: 5.326
Authors: A Rosemary Tate; Carles Majós; Angel Moreno; Franklyn A Howe; John R Griffiths; Carles Arús Journal: Magn Reson Med Date: 2003-01 Impact factor: 4.668
Authors: Andrew A Maudsley; Ovidiu C Andronesi; Peter B Barker; Alberto Bizzi; Wolfgang Bogner; Anke Henning; Sarah J Nelson; Stefan Posse; Dikoma C Shungu; Brian J Soher Journal: NMR Biomed Date: 2020-04-29 Impact factor: 4.044
Authors: Sandra Ortega-Martorell; Héctor Ruiz; Alfredo Vellido; Iván Olier; Enrique Romero; Margarida Julià-Sapé; José D Martín; Ian H Jarman; Carles Arús; Paulo J G Lisboa Journal: PLoS One Date: 2013-12-23 Impact factor: 3.240